A comparison of the thermogenic, metabolic and haemodynamic responses to infused adrenaline in lean and obese subjects. 1994

J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, UK.

The objective of this work was to study adrenoceptor sensitivity in vivo in a number of tissues in lean and obese humans. The thermogenic, metabolic and cardiovascular responses to a 90 min infusion of adrenaline were measured. The subjects were eleven obese subjects (Body Mass Index 36.0 +/- 1.2 kg/m2) and 10 non-obese subjects (Body Mass Index 21.9 +/- 0.7 kg/m2). Metabolic rate, heart rate, blood pressure, forearm blood flow, plasma palmitate turnover and oxidation were measured. Thermogenic responses to adrenaline were similar in the lean and obese groups (14.4 +/- 1.6 and 15.1 +/- 1.6 J/min/kg fat free mass respectively). Of the cardiovascular variables measured, only the increase in forearm blood flow during adrenaline infusion differed between lean and obese, being 3.9 +/- 0.5 and 1.9 +/- 0.3 ml/min/100 ml forearm respectively. Basal plasma palmitate turnover rates were lower in the obese when expressed per unit fat mass (2.32 +/- 0.17 and 7.61 +/- 1.20 mumol/min/kg fat mass respectively). Basal plasma palmitate oxidation rates were higher in the obese when expressed per unit fat free mass (1.53 +/- 0.19 and 0.82 +/- 0.12 mumol/min/kg fat free mass respectively). In response to adrenaline palmitate turnover increased similarly in both groups, but plasma palmitate oxidation rates fell in the obese whilst they were unchanged in the lean. In the basal state the obese do not appear to have a defect in fat oxidation, but their response to infused adrenaline may favour fat storage over oxidation. No thermogenic defect was shown in the obese.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010168 Palmitates Salts and esters of the 16-carbon saturated monocarboxylic acid--palmitic acid. Hexadecanoates,Palmitate
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing

Related Publications

J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
November 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
February 1989, The Journal of clinical endocrinology and metabolism,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
January 1982, Basic research in cardiology,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
May 1994, The American journal of clinical nutrition,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
January 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
August 1989, Appetite,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
November 2014, Pediatric exercise science,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
April 1999, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
May 1983, The American journal of physiology,
J Webber, and J Taylor, and H Greathead, and J Dawson, and P J Buttery, and I A Macdonald
October 2009, Molecular and cellular endocrinology,
Copied contents to your clipboard!